Avanos Medical, Inc. (AVNS) Misses Q1 EPS by 2c; reaffirms guidance

Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $191.7 million versus the consensus estimate of $205.6 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2023 EPS of $1.60-$1.80, versus the consensus of $1.70.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• Lake Shore Bancorp (LSBK) Tops Q2 EPS by 29c
• Sonoco (SON) Tops Q2 EPS by 2c; offers guidance